Send password reminder...
N- (2,6- dimethylergoline- 8- yl)- 2,2- dimethylpropanamide
Subscribe to New Research on N-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide
structure given in first source; RN given refers to cpd with unknown MF
Also Known As:
SDZ 208-911; SDZ-208-911
relevant articles (
Bio-Agent Context: Research Results
Heterocyclic Compounds: 60
Ergot Alkaloids: 156
Heterocyclic Compounds with 4 or More Rings
Schizophrenia (Dementia Praecox)
01/01/1990 - "
SDZ 208-911 and SDZ 208-912 could be effective against both the positive and negative symptoms of schizophrenia, while exhibiting a reduced incidence of dystonic and parkinsonian side-effects.
05/18/1994 - "
The aminoergolines SDZ-208-911, -208-912, and -212-327, weak partial D2 agonists with agonist/antagonist properties, are proposed as potential atypical antipsychotic agents with limited risk of extrapyramidal effects or hyperprolactinemia.
Related Drugs and Biologics
N- (2- chloro- 6- methylergoline- 8- yl)- 2,2- dimethylpropanamide
Antipsychotic Agents (Antipsychotics)
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
We wish to acknowledge and thank the US National Library of Medicine and Medline staff for providing access to their data.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.